We found TJP2 expression was positively correlated with IC50 of cisplatin, and TJP3 expression was positively correlated with IC50 of mitomycin C in bladder cancer cell lines (Table 2 and Supplement Figs. 2–4). This evidence concerns the gene TJP2 and urinary bladder cancer.